| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 2 585-593, Copyright © 1995 by American Association of Immunologists
ARTICLES |
W Krenger, KM Snyder, JC Byon, G Falzarano and JL Ferrara
Division of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Acute graft-vs-host disease (GVHD) is thought to be mediated by alloreactive T cells with a type 1 cytokine phenotype. To prevent the development of acute GVHD, we have successfully polarized mature donor T cells toward a type 2 cytokine phenotype ex-vivo by incubating them with murine rIL-4 in a primary MLC. Polarized type 2 T cells were then transplanted with T cell-depleted bone marrow cells into irradiated recipients across either MHC class II (bm12-->C57BL/6) or class I (bm1-- >C57BL/6) barriers, and the intensity of GVHD was measured by assessment of several in vitro and in vivo parameters. The injection of polarized type 2 T cells abrogated the mitogen-induced production of IFN-gamma by splenocytes from transplanted hosts on day 13 after bone marrow transplantation (BMT). Injection of polarized type 2 T cells failed to induce secretion of the effector phase cytokine TNF-alpha by splenocytes stimulated with LPS both in vitro and in vivo, and survival of transplanted mice after i.v. injection with LPS was significantly improved. Furthermore, cell-mixing experiments revealed that polarized type 2 T cells were able to inhibit type 1 cytokine responses induced by naive T cells after BMT. These data demonstrate that both polarized CD4+ and CD8+ type 2 alloreactive donor T cells can be generated in vitro from mature T cell populations. These cells function in vivo to inhibit type 1 T cell responses, and such inhibition attenuates the systemic morbidity of GVHD after BMT across both MHC class II or class I barriers in mice.
This article has been cited by other articles:
|
|
 |
|
  M. A. Hurchla, J. R. Sedy, and K. M. Murphy Unexpected Role of B and T Lymphocyte Attenuator in Sustaining Cell Survival during Chronic Allostimulation J. Immunol., May 15, 2007; 178(10): 6073 - 6082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Foley, U. Jung, A. Miera, T. Borenstein, J. Mariotti, M. Eckhaus, B. E. Bierer, and D. H. Fowler Ex Vivo Rapamycin Generates Donor Th2 Cells That Potently Inhibit Graft-versus-Host Disease and Graft-versus-Tumor Effects via an IL-4-Dependent Mechanism J. Immunol., November 1, 2005; 175(9): 5732 - 5743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Erdmann, Z.-G. Gao, U. Jung, J. Foley, T. Borenstein, K. A. Jacobson, and D. H. Fowler Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo Blood, June 15, 2005; 105(12): 4707 - 4714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. W. Blaser, S. Roychowdhury, D. J. Kim, N. R. Schwind, D. Bhatt, W. Yuan, D. F. Kusewitt, A. K. Ferketich, M. A. Caligiuri, and M. Guimond Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease Blood, January 15, 2005; 105(2): 894 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hashimoto, S. Asakura, S. Miyake, T. Yamamura, L. Van Kaer, C. Liu, M. Tanimoto, and T. Teshima Stimulation of Host NKT Cells by Synthetic Glycolipid Regulates Acute Graft-versus-Host Disease by Inducing Th2 Polarization of Donor T Cells J. Immunol., January 1, 2005; 174(1): 551 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Socie, J.-Y. Mary, M. Lemann, M. Daneshpouy, P. Guardiola, V. Meignin, L. Ades, H. Esperou, P. Ribaud, A. Devergie, et al. Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression Blood, January 1, 2004; 103(1): 50 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Jung, J. E. Foley, A. A. Erdmann, M. A. Eckhaus, and D. H. Fowler CD3/CD28-costimulated T1 and T2 subsets: differential in vivo allosensitization generates distinct GVT and GVHD effects Blood, November 1, 2003; 102(9): 3439 - 3446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Reddy, T. Teshima, G. Hildebrandt, D. L. Williams, C. Liu, K. R. Cooke, and J. L.M. Ferrara Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects Blood, April 1, 2003; 101(7): 2877 - 2885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. F. Hartwig, M. Robbers, C. Wickenhauser, and C. Huber Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death Blood, April 15, 2002; 99(8): 3041 - 3049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liu, B. E. Anderson, M. E. Robert, J. M. McNiff, S. G. Emerson, W. D. Shlomchik, and M. J. Shlomchik Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model system for the reversal of disease Blood, December 1, 2001; 98(12): 3367 - 3375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Lan, D. Zeng, M. Higuchi, P. Huie, J. P. Higgins, and S. Strober Predominance of NK1.1+TCR{alpha}{beta}+ or DX5+TCR{alpha}{beta}+ T Cells in Mice Conditioned with Fractionated Lymphoid Irradiation Protects Against Graft-Versus-Host Disease: "Natural Suppressor" Cells J. Immunol., August 15, 2001; 167(4): 2087 - 2096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Panoskaltsis-Mortari, D. H. Ingbar, P. Jung, I. Y. Haddad, P. B. Bitterman, O. D. Wangensteen, C. L. Farrell, D. L. Lacey, and B. R. Blazar KGF pretreatment decreases B7 and granzyme B expression and hastens repair in lungs of mice after allogeneic BMT Am J Physiol Lung Cell Mol Physiol, May 1, 2000; 278(5): L988 - L999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Arpinati, C. L. Green, S. Heimfeld, J. E. Heuser, and C. Anasetti Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells Blood, April 15, 2000; 95(8): 2484 - 2490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Sloand, S. Kim, J. P. Maciejewski, F. Van Rhee, A. Chaudhuri, J. Barrett, and N. S. Young Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo Blood, April 1, 2000; 95(7): 2269 - 2274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Tsukada, H. Akiba, T. Kobata, Y. Aizawa, H. Yagita, and K. Okumura Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation Blood, April 1, 2000; 95(7): 2434 - 2439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Taylor, A. Panoskaltsis-Mortari, R. J. Noelle, and B. R. Blazar Analysis of the Requirements for the Induction of CD4+ T Cell Alloantigen Hyporesponsiveness by Ex Vivo Anti-CD40 Ligand Antibody J. Immunol., January 15, 2000; 164(2): 612 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Pan, T. Teshima, G. R. Hill, D. Bungard, Y. S. Brinson, V. S. Reddy, K. R. Cooke, and J. L.M. Ferrara Granulocyte Colony-Stimulating Factor-Mobilized Allogeneic Stem Cell Transplantation Maintains Graft-Versus-Leukemia Effects Through a Perforin-Dependent Pathway While Preventing Graft-Versus-Host Disease Blood, June 15, 1999; 93(12): 4071 - 4078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Blazar, P. A. Taylor, A. Panoskaltsis-Mortari, A. H. Sharpe, and D. A. Vallera Opposing Roles of CD28:B7 and CTLA-4:B7 Pathways in Regulating In Vivo Alloresponses in Murine Recipients of MHC Disparate T Cells J. Immunol., June 1, 1999; 162(11): 6368 - 6377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Zeng, D. Lewis, S. Dejbakhsh-Jones, F. Lan, M. Garcia-Ojeda, R. Sibley, and S. Strober Bone Marrow NK1.1- and NK1.1+ T Cells Reciprocally Regulate Acute Graft versus Host Disease J. Exp. Med., April 5, 1999; 189(7): 1073 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Cooke, W. Krenger, G. Hill, T. R. Martin, L. Kobzik, J. Brewer, R. Simmons, J. M. Crawford, M. R.M. van den Brink, and J. L.M. Ferrara Host Reactive Donor T Cells Are Associated With Lung Injury After Experimental Allogeneic Bone Marrow Transplantation Blood, October 1, 1998; 92(7): 2571 - 2580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Martin, Y. Akatsuka, M. Hahne, and G. Sale Involvement of Donor T-Cell Cytotoxic Effector Mechanisms in Preventing Allogeneic Marrow Graft Rejection Blood, September 15, 1998; 92(6): 2177 - 2181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cerwenka, L. L. Carter, J. B. Reome, S. L. Swain, and R. W. Dutton In Vivo Persistence of CD8 Polarized T Cell Subsets Producing Type 1 or Type 2 Cytokines J. Immunol., July 1, 1998; 161(1): 97 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Koch, S. Choksi, L. Marcucci, and R. Korngold A Synthetic CD4-CDR3 Peptide Analog Enhances Skin Allograft Survival Across a MHC Class II Barrier J. Immunol., July 1, 1998; 161(1): 421 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Blazar, P. A. Taylor, A. Panoskaltsis-Mortari, and D. A. Vallera Rapamycin Inhibits the Generation of Graft-Versus-Host Disease- and Graft-Versus-Leukemia-Causing T Cells by Interfering with the Production of Th1 or Th1 Cytotoxic Cytokines J. Immunol., June 1, 1998; 160(11): 5355 - 5365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Fowler, B. Whitfield, M. Livingston, P. Chrobak, and R. E. Gress Non-Host-Reactive Donor CD8+ T Cells of Tc2 Phenotype Potently Inhibit Marrow Graft Rejection Blood, June 1, 1998; 91(11): 4045 - 4050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Hill, J. M. Crawford, K. R. Cooke, Y. S. Brinson, L. Pan, and J. L.M. Ferrara Total Body Irradiation and Acute Graft-Versus-Host Disease: The Role of Gastrointestinal Damage and Inflammatory Cytokines Blood, October 15, 1997; 90(8): 3204 - 3213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Halverson, G. N. Schwartz, C. Carter, R. E. Gress, and D. H. Fowler In Vitro Generation of Allospecific Human CD8+ T Cells of Tc1 and Tc2 Phenotype Blood, September 1, 1997; 90(5): 2089 - 2096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Glass, L. Uharek, M. Zeis, P. Dreger, H. Loffler, J. Steinmann, and N. Schmitz Allogeneic Peripheral Blood Progenitor Cell Transplantation in a Murine Model: Evidence for an Improved Graft-Versus-Leukemia Effect Blood, August 15, 1997; 90(4): 1694 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ferrara, K. Cooke, L Pan, and W Krenger The immunopathophysiology of acute graft-versus-host-disease Stem Cells, September 1, 1996; 14(5): 473 - 489. [Abstract]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
